IL33 and irritable bowel syndrome: While one of the first observations of IL-33-dependent epithelial proliferation and mucus production in the gut[5] suggests the promotion of mucosal repair and healing, dysregulated or uncontrolled IL-33 production may lead to the more pathogenic features characteristic of IBD, including epithelial barrier dysfunction, chronic, relapsing inflammation, and formation of fibrotic lesions.